PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
17-Aug-2022 Key Presentations at the Medical Devices & IVD Conference Released SAE Media Group reports: ahead of the conference in November, key presentations are released for the Medical Devices & IVD Conference
17-Aug-2022 Medical Billing Outsourcing Market Segmentation by Revenue, Present & Future Scenario To 2032 MARKITWIRED
17-Aug-2022 Cell Regeneration Medicine Market Overview, High Growth Opportunities, Segmentation, Trends By 2022-2032 MARKITWIRED
17-Aug-2022 Intubation Tube Market Size, Strategies and Opportunities Forecast 2022-32 MARKITWIRED
17-Aug-2022 3D Printed Surgical Models Market Application, Growth, Demand, Status, and Forecast from 2022 to 2032 MARKITWIRED
17-Aug-2022 Dental Chairs Market Status, Growth Opportunity, Size, Trends, Key Industry Outlook 2022-2032 MARKITWIRED
17-Aug-2022 Cataract Surgery Devices Market Demand, Overview, Size, Trend, and Key Players MARKITWIRED
17-Aug-2022 Skin Replacement Market Trends, Demand Growth Revenue Analysis Report to 2032 MARKITWIRED
17-Aug-2022 M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate M1 Kliniken AG
17-Aug-2022 HAEMATO AG publishes figures for Q2 2022: increase in revenues and EBIT compared to the previous quarter; confirmation of guidance for the full year 2022 HAEMATO AG
17-Aug-2022 Coronary Stents Market is expected to grow at a moderately high CAGR of 7% during the forecast period by 2026 MARKITWIRED
17-Aug-2022 Special Purpose Needles Market registering a CAGR of 7.4% during the forecast period by 2026 MARKITWIRED
17-Aug-2022 GCC Syringes and Needles Market is registering a CAGR of 8.8% over the forecast period by 2031 MARKITWIRED
17-Aug-2022 Antibodies Market is surpassing US$ 601.614 Billion by the end of 2031 MARKITWIRED
17-Aug-2022 Wearable Medical Devices Market to exhibit a CAGR of nearly 7% in the forecast period by 2031 MARKITWIRED
17-Aug-2022 Gerresheimer AG: Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source Gerresheimer AG
17-Aug-2022 Defence Therapeutics Inc.:  BREAKTHROUGH DISCOVERY: DEFENCE’S ACCUMTM VARIANT 'A1' CONVERTS MESENCHYMAL STROMAL CELLS INTO POTENT ANTIGEN PRESENTING CELLS SUITABLE FOR CANCER VACCINATION Defence Therapeutics Inc.
17-Aug-2022 Relief Therapeutics Appoints David McCullough as Head of U.S. Market Access Relief Therapeutics Holding SA
16-Aug-2022 Abivax announces a change in its governance ABIVAX
16-Aug-2022 With 3Brain AG's Accura-3D microchip, a first-in-class cell-electronic interface enters the market Newswire